Outsourced function substance mapping for multi-jurisdiction boards
Outsourced function substance mapping is the exercise a board runs when a company's core income-generating activities are performed, wholly or in part, by an external provider, and the board needs to know whether enough decision-making still sits inside the company to satisfy the substance test that applies to it. The output is a working record, not an opinion: which functions are outsourced, who exercises judgment over each one, and where that judgment is actually documented rather than merely asserted. Groups that skip this exercise usually discover the gap only when a regulator, an auditor or a counterparty asks for the record and finds that none exists.
A group holding company keeps its investment management outsourced to a manager in another jurisdiction, its accounting outsourced to a local firm, and its board of directors meeting twice a year by video call. Each arrangement is ordinary on its own. Together they raise the single question a substance regime is built to test: does the board itself still direct the activity that generates the company's income, or has direction moved to the provider without anyone recording that it has moved.
This page sets out when the mapping exercise becomes necessary, what it produces and in what order, and where the advisory work under it stops.
The situation this work addresses
The pattern recurs across holding structures, fund vehicles and licensed entities alike. A board of directors delegates day-to-day management, investment decisions or accounting to an external provider, often because the provider already has the staff and systems the company has no reason to build itself. The delegation is efficient. It is also the exact fact pattern a substance regime is designed to test, because a regime does not stop at asking whether outsourcing happened; it asks whether the company, through its own board, still directs the activity that generates its income. For a comparable question worked through in a single centre, see outsourced function substance mapping in the Abu Dhabi Global Market.
The mapping work becomes necessary the moment a company cannot answer that question with a document, only with an assertion. A director who says "the board approves everything the manager proposes" has described a process, not evidence. Evidence is a paper trail: agendas circulated before a meeting, minutes that show a board member engaged with a proposal rather than signing it unread, and records showing where a genuine decision was actually taken. Outsourced function substance mapping produces that trail, or shows the group precisely where it is missing before an outside party asks for it.
What triggers it and why the timing matters
Three situations bring the exercise forward from a background compliance task to something needing attention this quarter. A company adds or replaces an outsourced provider, which resets the question of who exercises judgment over the delegated function. A company is drawn into a cross-border structure through an acquisition and inherits an outsourcing arrangement it did not design and cannot yet describe. Or a statutory filing approaches that requires the board to confirm, in writing, that the company meets the substance test applicable to it.
That third situation carries the least room to move. Once the filing confirming the company's substance position is submitted, the position it states becomes the company's own record; it is not withdrawn if it turns out to be incomplete, only corrected on the file after the fact, and a correction filed once a regulator has already looked reads very differently from a position taken correctly the first time.
Timing matters because the mapping exercise takes longer than boards expect. Locating who within the outsourced provider actually exercises discretion, and matching that against what the company's constitutional documents authorise the board to delegate in the first place, is not a desk review completed in an afternoon. A board that starts the exercise the week before a filing is due is choosing between an incomplete answer and a late one.
A holding company whose sole outsourced manager resigns the arrangement shortly before the annual filing is due presents two problems at once, and only one of them is fixable after the deadline: replacing the manager can happen at any point, but restating a filing already made cannot be undone, only corrected against a record that already exists.
A group weighing whether its own board resolutions actually cover the ground a substance test will ask about should confirm the position before the next filing window opens, not after a regulator has queried the last one.
Write to info@hreithlaw.com with the jurisdiction and the structure if a filing date is already fixed. Check what your jurisdiction requires Check what your jurisdiction requires
What the work produces, in sequence
The engagement produces four artefacts, built in this order and each usable on its own.
- A function inventory: every activity outsourced by the company, matched to the provider actually performing it and the contract under which it is performed.
- A decision-point map showing, function by function, where judgment is exercised and by whom, distinguishing genuine board oversight from formal sign-off of decisions already made elsewhere.
- A substance memorandum setting out, for each jurisdiction in the structure, what the mapping shows and where a gap, if any, sits against what that jurisdiction requires.
- A set of board resolution templates the company's own directors can use to close the gaps the memorandum identifies, so the next board meeting produces a documented decision rather than another undocumented approval.
Each deliverable stands alone. A group that only needs the function inventory to brief its own auditor is not obliged to commission the rest, and a group that already has an inventory can start at the decision-point map. For the reasoning most boards ask for once the map exists, see what board resolutions this typically requires, and for the diagnostic that sits alongside this exercise, see substance assessment.
Where this differs by jurisdiction
The substance test itself is set locally, and the jurisdictions inside a single structure are rarely covered by the same regime. Some offshore centres, including the British Virgin Islands and the Cayman Islands, apply a defined substance regime to specified categories of business, and the tests those regimes apply are not identical to one another; a comparison of how the two set the control question is set out at a comparison of the BVI and Cayman substance and control tests. Some onshore jurisdictions, including the United Arab Emirates, tie a substance requirement to particular licensed activities rather than applying it to companies generally. Others in the same structure may sit outside any substance regime altogether and turn instead on ordinary company law questions about where the board in fact meets and decides, including how far a company's own constitutional documents can restrict what the board delegates in the first place; the point recurs, in a different context, in the discussion of how articles can restrict share transfers under Luxembourg company law.
This is why the mapping exercise is run once across the whole structure rather than jurisdiction by jurisdiction. A gap in one entity's substance position is rarely contained to that entity if the same outsourced provider, and the same undocumented sign-off practice, sits behind two or three entities in the same group.
Where a jurisdiction's register already discloses the company's directors and its outsourcing arrangement touches a beneficial owner filing, an incomplete or inconsistent entry does not sit quietly once made. Correcting it means filing a correction against an entry that is already public and already visible to whoever checked the register before the correction went in, not withdrawing the original entry as if it had never been filed.
What this service does not include
This work does not include acting as a director, secretary, nominee shareholder or trustee for the company, and it does not include supplying, sourcing or arranging any person to hold one of those offices. It also does not include any activity for which a trust or corporate service provider licence is required. The boundary is not a matter of house preference. In a number of the jurisdictions this mapping exercise covers, arranging for a person to act as a director or nominee is itself a licensed activity, and a firm without that licence has no lawful basis to offer it, regardless of how the request is phrased.
What the engagement delivers instead is the analysis a licensed provider, or the company's own board, then acts on: the applicable requirement mapped against the actual outsourcing arrangement, the decision points identified, board resolution templates drafted, and the exposure to the company and to its directors personally set out in terms the board can act on without further translation.
Before relying on any existing substance position, a board should be able to confirm the following without hesitation:
- Which functions are outsourced, to whom, and under what contract
- Who inside the group actually exercises judgment over each outsourced decision
- What the constitutional documents authorise the board to delegate
- Which filing or register deadline falls next, and what it will state
A board that cannot confirm at least the first two of these is not yet in a position to sign the next filing with confidence, whatever the previous year's filing said. Assess your director exposure before the next filing window, not after a query arrives. Check what your jurisdiction requires Write to info@hreithlaw.com with the jurisdiction and the structure.
Frequently asked questions
- What happens if outsourced function substance mapping is not addressed?
- The company continues to rely on an assertion rather than a record, and the gap only becomes visible when a regulator, auditor or counterparty asks for the evidence behind a filing already made. At that point the options are narrower than they would have been beforehand, because the position on record cannot be quietly revised.
- How often should outsourced function substance mapping be reviewed?
- It should be reviewed whenever an outsourced provider changes, whenever the company enters a new jurisdiction through a group restructuring, and in any event before each statutory filing that requires the board to confirm its substance position. A mapping done two provider changes ago no longer describes the current arrangement.
- Does outsourced function substance mapping change for a foreign-owned company?
- The mapping method is the same, but a foreign-owned company more often has its outsourced functions performed by an affiliate of its own parent rather than by an independent third party, which makes the decision-point map harder to draw honestly and more important to get right.
- What does outsourced function substance mapping require in practice?
- It requires access to the contracts governing each outsourced function, the minutes and resolutions of the board for a representative period, and a candid account from at least one director of how a recent decision was actually made, not how the process is supposed to work on paper.
- Who inside the company is responsible for outsourced function substance mapping?
- Responsibility sits with the board of directors as a whole, not with whichever director happens to liaise with the outsourced provider. A board resolution recording who is tasked with keeping the mapping current is itself one of the gaps this exercise most commonly finds missing.
Henrik Aas, expert author. Henrik focuses on the governance of outsourced and delegated functions across multi-jurisdiction corporate groups, with particular attention to how substance and control tests interact with board decision-making in practice. He advises boards on mapping outsourcing arrangements against the requirements that apply in each jurisdiction in a structure, and on the documentation a board needs to support the position it takes.